Design and synthesis of selective imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine inhibitors of leucine-rich repeat kinase 2 (LRRK2) using a checkpoint kinase 1 (CHK1)-derived crystallographic surrogate

被引:0
|
作者
Ray, Stuart [1 ]
机构
[1] Vernalis, Chem, Cambridge, Great Abington, England
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 256卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
53
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Synthesis and anticancer evaluation of some new pyrazolo[3,4-d][1,2,3]triazin-4-ones, pyrazolo[1,5-a]pyrimidines, and imidazo[1,2-b]pyrazoles clubbed with carbazole
    Bondock, Samir
    Alqahtani, Salwa
    Fouda, Ahmed M.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2021, 58 (01) : 56 - 73
  • [42] Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors
    Liu, Chunjian
    Lin, James
    Moslin, Ryan
    Tokarski, John S.
    Muckelbauer, Jodi
    Chang, ChiehYing
    Tredup, Jeffrey
    Xie, Dianlin
    Park, Hyunsoo
    Li, Peng
    Wu, Dauh-Rurng
    Strnad, Joann
    Zupa-Fernandez, Adriana
    Cheng, Lihong
    Chaudhry, Charu
    Chen, Jing
    Chen, Cliff
    Sun, Huadong
    Elzinga, Paul
    D'arienzo, Celia
    Gillooly, Kathleen
    Taylor, Tracy L.
    McIntyre, Kim W.
    Salter-Cid, Luisa
    Lombardo, Louis J.
    Carter, Percy H.
    Aranibar, Nelly
    Burke, James R.
    Weinstein, David S.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (03): : 383 - 388
  • [43] Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as dual inhibitors of c-Met and VEGFR2 kinases
    Matsumoto, Shigemitsu
    Miyamoto, Naoki
    Hirayama, Takaharu
    Oki, Hideyuki
    Okada, Kengo
    Tawada, Michiko
    Iwata, Hidehisa
    Miki, Hiroshi
    Nakamura, Kazuhide
    Hori, Akira
    Imamura, Shinichi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [44] Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2
    Nie, Zhe
    Perretta, Carin
    Erickson, Philip
    Margosiak, Stephen
    Almassy, Robert
    Lu, Jia
    Averill, April
    Yager, Kraig M.
    Chu, Shaosong
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (15) : 4191 - 4195
  • [45] Identification of imidazo[1,2-b] pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signalling
    Moslin, R.
    Gardner, D.
    Santella, J.
    Zhang, Y.
    Duncia, J. V.
    Liu, C.
    Lin, J.
    Tokarski, J. S.
    Strnad, J.
    Pedicord, D.
    Chen, J.
    Blat, Y.
    Zupa-Fernandez, A.
    Cheng, L.
    Sun, H.
    Chaudhry, C.
    Huang, C.
    D'Arienzo, C.
    Sack, J. S.
    Muckelbauer, J. K.
    Chang, C.
    Tredup, J.
    Xie, D.
    Aranibar, N.
    Burke, J. R.
    Carter, P. H.
    Weinstein, D. S.
    MEDCHEMCOMM, 2017, 8 (04) : 700 - 712
  • [46] Design of new disubstituted imidazo[1,2-b]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluation
    Elie, Jonathan
    Feizbakhsh, Omid
    Desban, Nathalie
    Josselin, Beatrice
    Baratte, Blandine
    Bescond, Amandine
    Duez, Julien
    Fant, Xavier
    Bach, Stephane
    Marie, Dominique
    Place, Matthieu
    Ben Salah, Sami
    Chartier, Agnes
    Berteina-Raboin, Sabine
    Chaikuad, Apirat
    Knapp, Stefan
    Carles, Fabrice
    Bonnet, Pascal
    Buron, Frederic
    Routier, Sylvain
    Ruchaud, Sandrine
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 1840 - 1853
  • [47] Convergent and streamlined synthesis of 6-etherified imidazo[1,2-b] pyridazine-2-amine derivatives possessing VEGFR-2 kinase inhibitory activity
    Ishimoto, Kazuhisa
    Sawai, Yasuhiro
    Fukuda, Naohiro
    Nagata, Toshiaki
    Ikemoto, Tomomi
    TETRAHEDRON, 2013, 69 (40) : 8564 - 8571
  • [48] Synthesis and preliminary structure-activity relationship study of 2-aryl-2H-pyrazolo[4,3-c]quinolin-3-ones as potential checkpoint kinase 1 (Chk1) inhibitors
    Malvacio, Ivana
    Cuzzolin, Alberto
    Sturlese, Mattia
    Vera, D. Mariano A.
    Laura Moyano, E.
    Moro, Stefano
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 33 (01) : 171 - 183
  • [49] Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a] pyrimidine scaffold with apoptotic activity
    Ali, Ghada M. E.
    Ibrahim, Diaa A.
    Elmetwali, Amira M.
    Ismail, Nasser S. M.
    BIOORGANIC CHEMISTRY, 2019, 86 : 1 - 14
  • [50] Design and synthesis of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as PDE 4B inhibitors endowed with bronchodilator activity
    Abd El-Aleam, Rehab H.
    George, Riham F.
    Lee, Kevin J.
    Keeton, Adam B.
    Piazza, Gary A.
    Kamel, Amr A.
    El-Daly, Mahmoud E.
    Hassan, Ghaneya S.
    Abdel-Rahman, Hamdy M.
    ARCHIV DER PHARMAZIE, 2019, 352 (08)